Recent Updates
Recently added Catalysts
COLL Positive Sentiment

DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln

Monday, July 20, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Collegium Pharmaceutical has signed a lease for 40,288 square feet at One Lincoln in Boston's Financial District. This move signifies the company's growth and commitment to expanding its presence in a prime location. One Lincoln, a recently renovated Class A office tower, is designed to be a next-generation workplace.
Price reaction · baseline $36.08 (2026-07-17 close) · hit pre-market · clean, no other COLL news in the window
day 0 close · peak
-1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Collegium Pharmaceutical secures a significant office space.
  • The new location enhances Collegium's operational capabilities.
  • One Lincoln is a modern, Class A office tower.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache

Full Press Release Details

BOSTON--(BUSINESS WIRE)--DivcoWest, a DivCore Capital company and national commercial real estate investment firm, today announced that Collegium Pharmaceutical, a leading biopharmaceutical company, has signed a lease for 40,288 square feet on floors 11 and 12 at One Lincoln in Boston’s Financial District. The 36‑story, 1.1‑million‑square‑foot Class A office tower completed a transformative renewal in 2025 and now serves as a landmark next-generation workplace for world-class established and gr

Frequently Asked Questions

What is the size of Collegium's new office space?

Collegium Pharmaceutical has leased 40,288 square feet.

Where is Collegium's new office located?

The new office is located at One Lincoln in Boston's Financial District.

What type of building is One Lincoln?

One Lincoln is a Class A office tower.

Who announced the lease signing?

DivcoWest announced the lease signing for Collegium Pharmaceutical.

ShareAdd on Google
Tags: COLL Viatris Investor Conferences Healthcare Collegium Pharmaceutical DivcoWest One Lincoln Boston commercial real estate
Last updated: Jul 20, 2026

Biotech snapshot

Cash runway
$150M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DFN-15 ActivePhase 3
Migraine Headache →

Catalyst track record

+28%
best trade around COLL's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for COLL.

See every catalyst's timing & PoA →